Digestive Remedies in Brazil

May 2024 | 29 pages | ID: DB02DA46CE1EN
Euromonitor International Ltd

Abstracts

Digestive remedies is set to show double-digit growth in current value terms in Brazil in 2023; a result primarily driven by antacids and diarrhoeal remedies. Together, these two categories account for more than half of value sales of digestive remedies in Brazil. Different reasons have propelled the growth of these two categories.

Euromonitor International's Digestive Remedies in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Digestive Remedies market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Digestive Remedies in Brazil
Euromonitor International
March 2024

LIST OF CONTENTS AND TABLES

DIGESTIVE REMEDIES IN BRAZIL
KEY DATA FINDINGS

2023 DEVELOPMENTS

Outbreak of diarrhoea cases helps drive growth for digestive remedies in 2023
Demand for indulgent foods underpins the growth of antacids
Anvisa approves changes to medicines labelling
PROSPECTS AND OPPORTUNITIES
Digestive remedies to maintain a crucial role in Brazil’s consumer health industry
Long-term effects of the COVID-19 pandemic likely to positively impact forecast growth
Gastrointestinal reactions to the use of Ozempic may impact growth
CATEGORY DATA
Table 1 Sales of Digestive Remedies by Category: Value 2018-2023
Table 2 Sales of Digestive Remedies by Category: % Value Growth 2018-2023
Table 3 NBO Company Shares of Digestive Remedies: % Value 2019-2023
Table 4 LBN Brand Shares of Digestive Remedies: % Value 2020-2023
Table 5 Forecast Sales of Digestive Remedies by Category: Value 2023-2028
Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2023-2028
CONSUMER HEALTH IN BRAZIL
EXECUTIVE SUMMARY
Consumer health in 2023: The big picture

2023 KEY TRENDS

Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
Table 8 Life Expectancy at Birth 2018-2023
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2018-2023
Table 10 Sales of Consumer Health by Category: % Value Growth 2018-2023
Table 11 NBO Company Shares of Consumer Health: % Value 2019-2023
Table 12 LBN Brand Shares of Consumer Health: % Value 2020-2023
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2018-2023
Table 14 Distribution of Consumer Health by Format: % Value 2018-2023
Table 15 Distribution of Consumer Health by Format and Category: % Value 2023
Table 16 Forecast Sales of Consumer Health by Category: Value 2023-2028
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources